The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome;Die benzamide tiaprid, sulpirid und amisulprid in der therapie des Tourette-syndroms. Eine standortbestimmung

Nervenarzt

Volumn 78, Issue 3, 2007, Pages 264-271

  Muller Vahl K R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Benzamides; Sulpiride; Tiapride; Tic; Tourette's syndrome

Indexed keywords

AMISULPRIDE; BENZAMIDE DERIVATIVE; PIMOZIDE; RISPERIDONE; SULPIRIDE; TIAPRIDE;

COMPARATIVE STUDY; DRUG EFFICACY; GILLES DE LA TOURETTE SYNDROME; HUMAN; REVIEW;

ANTI-DYSKINESIA AGENTS; BENZAMIDES; DOPAMINE ANTAGONISTS; GERMANY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SULPIRIDE; TIAPRIDE; TOURETTE SYNDROME; TREATMENT OUTCOME;

EID: 33847759552     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-006-2131-x     Document Type: Review

References (27)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text revision (DSM-IV-TR). APA, Washington
2. Bock N, Moll GH, Wicker M et al. (2005) Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system. Pharmacopsychiatry 37:163-167
3. Caine ED, Polinsky RJ, Kartzinel R et al. (1979) The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiatry 136:317-320
4. Chouza C, Romero S, Lorenzo J et al. (1982) Clinical trial of tiapride in patients with dyskinesia. Sem Hop 58:725-733
5. Eggers C, Rothenberger A, Berghaus U (1988) Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 237:223-239
6. Fountoulakis KN, Iacovides A, Kaprinis GS (2004) Successful treatment of Tourette's disorder with amisulpride. Ann Pharmacother 38:901
7. Freeman RD, Fast DK, Burd L et al. (2000) An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 42:436-447
8. George MS, Trimble MR, Robertson MM (1993) Fluvoxamine and sulpiride in comorbid obsessive-compulsive disorder and Gilles de la Tourette syndrome. Hum Psychopharmacol 8:327-334
9. Gilles de la Tourette G (1885) Etude sur une affection nerveuse caracterisee par de l'incoodination motrice accompagnee d'echolalie et de coprolalie. Arch Neurol 9:19-42
10. Jankovic J (2001) Tourette's syndrome. N Engl J Med 345:1184-1192
11. Klepel H, Gebelt H, Koch RD et al. (1988) Treatment of extrapyramidal hyperkineses in childhood with tiapride. Psychiatr Neurol Med Psychol (Leipz) 40:516-522
12. Kossoff EH, Singer HS (2001) Tourette syndrome: clinical characteristics and current management strategies. Paediatr Drugs 3:355-363
13. Lipcsey A (1983) Gilles de la Tourette's disease. Sem Hop 59:695-696
14. Mason A, Banerjee S, Eapen V et al. (1998) The prevalence of Tourette syndrome in a mainstream school population. Dev Med Child Neurol 40:292-296
15. Meisel A, Winter C, Zschenderlein R et al. (2004) Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride. Mov Disord 19:991-992
16. Müller-Vahl KR (2002) The treatment of Tourette's syndrome: current opinions. Expert Opin Pharmacother 3:899-914
17. Müller-Vahl K, Kaufmann J, Dengler R et al. (2004) Frontal white matter abnormalities in Tourette Syndrome as detected by voxel-based morphometry and magnetization transfer imaging. Nervenarzt 75(Suppl 2):S230
18. Müller-Vahl KR, Geomelas M, Makowski L et al. (2004) Clinical Symptoms in Tourette syndrome: a prospective study in 480 patients. Poster abstracts. 4th International Scientific Symposium on Tourette-Syndrome, Cleveland, Ohio
19. Pappert EJ, Goetz CG, Louis ED et al. (2003) Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology 61:936-940
20. Peterson BS, Cohen DJ (1998) The treatment of Tourette's syndrome: multimodal, developmental intervention. J Clin Psychiatry 59(Suppl 1):62-72
21. Robertson MM (2000) Tourette syndrome, associated conditions and the complexities of treatment. Brain 123(Pt 3):425-462
22. Robertson MM, Schnieden V, Lees AJ (1990) Management of Gilles de la Tourette syndrome using sulpiride. Clin Neuropharmacol 13:229-235
23. Silay YS, Jankovic J (2005) Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs 10:365-380
24. Singer HS (2000) Current issues in Tourette syndrome. Mov Disord 15:1051-1063
25. Singer HS, Wendlandt JT (2001) Neurochemistry and synaptic neurotransmission in Tourette syndrome. Adv Neurol 85:163-178
26. Trillet M, Moreau T, Dalery J et al. (1990) Treatment of Gilles de la Tourette's disease with amisulpiride. Presse Med 19:175
27. Yvonneau M, Bezard P (1970) Apropos of a case of Gilles de la Tourette's disease blocked by sulpiride. Psycho-biological study. Encephale 59:439-459